M. Lebwohl, “Bimekizumab Efficacy Through 3 Years in Patients with Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from BE BRIGHT”, J of Skin, vol. 8, no. 1, p. s307, Jan. 2024.